Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0A5J stock hub

LON/0A5J has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0A5Jis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0A5J

In the news

Latest news · LON/0A5J

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.2

P25 n/aP50 n/aP75 n/a

Trailing P/E17.1

P25 n/aP50 n/aP75 n/a

ROE20.2

P25 n/aP50 n/aP75 n/a

ROIC11.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0A5J market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

EUR

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	3,503
Employees Change	-107%
Employees Change Percent	-2.96
Enterprise value	EUR 2.7B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Isin	DE000A2GS5D8
Last refreshed	2026-05-10
Market cap	EUR 2B
Price	EUR 46.4
Price currency	EUR
Rev Per Employee	293,461.46x
Sic	2834
Symbol	lon/0A5J
Website	https://ir.dermapharm.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.84%
EV Earnings	23.47x
EV/EBIT	13.03x
EV/EBITDA	11.36x
EV/FCF	16.62x
EV/Sales	2.66x
FCF yield	8.25%
Forward P/E	16.25x
P/B ratio	3.28x
P/E ratio	17.12x
P/S ratio	1.92x
PE Ratio10 Y	22.31x
PE Ratio3 Y	21.13x
PE Ratio5 Y	21.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.08%
EBITDA Margin	22.47%
FCF margin	15.87%
Gross margin	64.98%
Gross Profit	EUR 668M
Gross Profit Growth	2.12%
Gross Profit Growth Q	6.04%
Gross Profit Growth3 Y	5.68%
Gross Profit Growth5 Y	11.03%
Net Income	EUR 115.5M
Net Income Growth	16.37%
Net Income Growth Q	79.87%
Net Income Growth3 Y	-0.46%
Net Income Growth5 Y	9.06%
Pretax Margin	15.57%
Profit Margin	11.24%
Profit Per Employee	EUR 32,975
ROA	6.93
Roa5y	9.36
ROCE	12.83
ROE	20.22
Roe5y	25.44
ROIC	11.09
Roic5y	14.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22%
Cagr3y	4.34%
Cagr5y	-5.6%
Div CAGR3	-5.07%
Div CAGR5	0.36%
EPS Growth	16.37
EPS Growth Q	80.38
EPS Growth3 Y	-0.46
EPS Growth5 Y	9.12
FCF Growth	14.64%
FCF Growth Q	37.83%
FCF Growth3 Y	-9.16%
FCF Growth5 Y	15.68%
OCF Growth	13.79%
OCF Growth Q	31.57%
OCF Growth3 Y	-7.39%
OCF Growth5 Y	11.82%
Revenue Growth	-1.43x
Revenue Growth Q	1.44x
Revenue Growth3 Y	4.23x
Revenue Growth5 Y	7.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.55
Assets	EUR 1.9B
Cash	EUR 178.4M
Current Assets	EUR 608.1M
Current Liabilities	EUR 296.6M
Debt	EUR 922.9M
Debt EBITDA	EUR 3.89
Debt Equity	EUR 1.53
Debt FCF	EUR 5.66
Equity	EUR 602.6M
Interest Coverage	4.86
Liabilities	EUR 1.3B
Long Term Assets	EUR 1.3B
Long Term Liabilities	EUR 1B
Net Cash	EUR -744.5M
Net Cash By Market Cap	EUR -37.66
Net Debt EBITDA	EUR 3.22
Net Debt Equity	EUR 1.24
Net Debt FCF	EUR 4.56
Tangible Book Value	EUR -237.1M
Tangible Book Value Per Share	EUR -4.4
WACC	7.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.05
Inventory Turnover	1.23
Net Working Capital	EUR 253.5M
Quick ratio	0.95
Working Capital	EUR 314M
Working Capital Turnover	EUR 3.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	3.06%
Dividend Growth Years	1%
Dividend per share	EUR 0.77
Dividend Years	6
Dividend Yield	1.65%
Ex Div Date	2025-06-27
Last Dividend	EUR 0.77
Payout Frequency	Annual
Payout Ratio	36.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.98%
200-day SMA	36.93
3Y total return	13.59%
50-day SMA	43.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-25.04%
All Time High	91.95
All Time High Change	-49.54%
All Time High Date	2022-01-03
All Time Low	30.15
All Time Low Change	53.9%
All Time Low Date	2024-10-30
ATR	1.03
Beta	0.86
Ch YTD	18.82
High	47.15
High52	47.65
High52 Date	2026-05-06
High52ch	-2.62%
Low	46.05
Low52	31.85
Low52 Date	2025-09-25
Low52ch	45.68%
Ma50ch	7.66%
Price vs 200-day SMA	25.64%
RSI	59.32
RSI Monthly	62.39
RSI Weekly	73.18
Sharpe ratio	0.62x
Sortino ratio	1.12
Total Return	1.65%
Tr YTD	18.82
Tr1m	6.61%
Tr1w	0.87%
Tr3m	28.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 206.4M
Operating Income Growth	6.55
Operating Income Growth Q	9.09
Operating Income Growth3 Y	-5.76
Operating Income Growth5 Y	11.05
Operating margin	20.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,465,810%
Net Borrowing	53,439,927.6
Shares Insiders	7.38%
Shares Institutions	11.9%
Shares Qo Q	-1.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 163.2M
Average Volume	5,282.9x
Bv Per Share	11.25
CAPEX	EUR -36.7M
Ch1m	6.61
Ch1w	0.87
Ch1y	18.82
Ch3m	28.76
Ch3y	5.58
Ch5y	-34.27
Ch6m	40.19
Change	-0.75%
Change From Open	-1.28
Close	46.75
Days Gap	0.53
Depreciation Amortization	24,323,826
Dollar Volume	766,760
Earnings Date	2026-05-13
EBIT	EUR 206.4M
EBITDA	EUR 230.9M
EPS	EUR 2.15
F Score	6
FCF	EUR 163.2M
FCF EV Yield	6.02x
Financing CF	-40,221,625
Fiscal Year End	December
Founded	1,991
Goodwill	507,824,637.6
Graham Number	29.37144
Graham Upside	-36.7
Income Tax	EUR 45.5M
Investing CF	-85,701,914
Is Primary Listing	0
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Lynch Fair Value	EUR 24.56
Lynch Upside	-47.07
Ma150	38.18
Ma150ch	21.54%
Ma20	45.84
Ma20ch	1.21%
Net CF	71,634,901
Next Earnings Date	2026-05-13
Open	47
P FCF Ratio	12.12
P OCF Ratio	9.89
Payment Date	2025-07-01
Position In Range	31.82
Ppne	275,548,923.9
Price Date	2026-05-08
Price EBITDA	EUR 8.56
Relative Volume	3.13x
Revenue	1,027,995,503x
Tax By Revenue	4.43x
Tax Rate	28.42%
Tr6m	40.19%
Volume	16,525
Z Score	2.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0A5J dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$0.77 annual per share

Payout ratio

+36.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+0.4%

1 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2025-06-27

Performance

LON/0A5J stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0A5J?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.9%

Share of float held by funds and institutions

Insider ownership

+7.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0A5J momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.3

Neutral momentum band

Price vs 200-day MA

+25.6%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0A5J

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A5J stock rating?

lon/0A5J is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A5J analysis?

The full report lives at /stocks/lon/0A5J/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A5J?

The latest report frames lon/0A5J around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A5J page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.